← All organizations
Highest phase reached
Phase 3
First clinical trial
Jun 1, 2002Last known activity
Sep 22, 2025
Timeline
1960s
- Jan 1, 1964
American Society of Clinical Oncology— Founded
Drugs by trial phase (42 distinct, 17 trials)
Phase 3 (2 own, 0 via acquisition)
Phase 2 (25 own, 0 via acquisition)
Phase 1 (10 own, 0 via acquisition)
Other trials (5 own, 0 via acquisition)
Indications
Studied for
- Carcinoma, Ovarian Epithelial
- Carcinoma, Squamous Cell
- Glioblastoma
- Head and Neck Neoplasms
- Hodgkin Disease
- Hypersensitivity
- Lymphoma
- Lymphoma, Non-Hodgkin
- Melanoma
- Multiple Myeloma
- Mycoses
- Mycosis Fungoides
- Neoplasm Metastasis
- Neoplasms, Plasma Cell
- Neoplasms, Squamous Cell
- Ovarian Neoplasms
- Prostatic Neoplasms
- Sarcoma
Recent trials (18)
- NCT06964009CollaboratorPhase 1Sep 22, 2025
- NCT06895473CollaboratorPhase 2Apr 1, 2025
- NCT06377852Lead sponsorPhase 3Oct 29, 2024
- NCT06377852OfficialPhase 3Oct 29, 2024
- NCT05934838CollaboratorPhase 1Oct 4, 2023
- NCT04754399CollaboratorPhase 2Apr 16, 2021
- NCT04377087CollaboratorPhase 2May 31, 2020
- NCT04134325CollaboratorEarly Phase 1Sep 1, 2019
- NCT02693535Lead sponsorPhase 2Mar 1, 2016
- NCT02207010CollaboratorEarly Phase 1Jul 1, 2014
- NCT01626066CollaboratorPhase 1Jun 1, 2012
- NCT01184885CollaboratorN/AJul 1, 2010
- NCT01020305CollaboratorPhase 1/Phase 2Oct 1, 2009
- NCT00577642CollaboratorPhase 2Oct 1, 2007
- NCT00142454CollaboratorPhase 1Aug 1, 2005
Details
- Founded
- Alexandria, VA, US Jan 1, 1964
- Last known activity
- Sep 22, 2025